In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
about
Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin.Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method.Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time.In vitro activities of irloxacin and E-3846, two new quinolonesCompetition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology.Use of cryomicrotomy to study gastric diffusion of amoxicillin in guinea pigs.Activity of cefixime against Helicobacter pylori and affinities for the penicillin-binding proteins.Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.Dirithromycin: a new macrolide.A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome.Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan.Multicenter Spanish study of ciprofloxacin susceptibility in gram-negative bacteria. The Spanish Study Group on Quinolone Resistance.In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
P2860
Q33743899-30B4C42B-EC56-4997-8D61-ED4A98DCB1BBQ34110118-264F1700-44AC-4C54-8EC7-0587FC2EB87AQ35139348-11B3E6E3-42AB-44F9-BCAD-6CB6742CC064Q35263647-C5FAFB55-AEFC-4149-90BA-005BBBB1E2C7Q39472196-D3A74D97-0ED8-497A-AC52-7DF4EBA65FE1Q39779423-F880B718-9B15-4448-BFDF-C5319937CB4CQ39817382-C9ACC877-A3AC-46B1-B6E0-61A5A82DB428Q40086079-C9271ECB-DB06-44C3-921A-0EF09107A897Q40925660-435A7ACD-98D0-49CA-B3FD-ED58F25970AFQ44281134-DFA632EF-E562-4374-8858-1CA9B67CC2A0Q44796550-42090E31-9DC3-4FE9-8338-64FC1F9DE01FQ54174689-6E7BD1C6-FA9D-4B0F-B643-BFDAFF94FEA1Q54316634-EC76B7A4-7396-45AB-8A94-DE52B0FA5840
P2860
In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
description
1989 nî lūn-bûn
@nan
1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
@ast
In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
@en
type
label
In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
@ast
In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
@en
prefLabel
In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
@ast
In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
@en
P2093
P2860
P356
P1476
In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori
@en
P2093
E García Sánchez
J A García-Rodríguez
J E García Sánchez
M I García García
P2860
P304
P356
10.1128/AAC.33.9.1650
P407
P577
1989-09-01T00:00:00Z